BAJAJ BROKING

Notification
No new Notification messages
Grand Continent Hotels IPO is Open!
Apply for the Grand Continent Hotels IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Dishman Carbogen’s France Arm Gets GMP Compliance Certificate

Synopsis:

Dishman Carbogen’s France-based Carbogen Amcis SAS receives GMP compliance certification for its Saint-Beauzire site from ANSM, strengthening its position in the global pharmaceutical sector.

 

Dishman Carbogen’s France-based arm, Carbogen Amcis SAS, has secured the Good Manufacturing Practice (GMP) compliance certificate for its Saint-Beauzire site. The certification was granted by the National Agency for the Safety of Medicine and Health Products (ANSM), the French regulatory authority. The GMP certificate validates the quality and safety standards of the site, strengthening Carbogen Amcis SAS’s position in the global pharmaceutical industry.

The Saint-Beauzire site plays a crucial role in the production of active pharmaceutical ingredients (APIs) and highly potent drugs. With this certification, Carbogen Amcis SAS ensures that its manufacturing processes adhere to stringent European quality standards. This achievement is expected to boost investor confidence and positively impact the Dishman Carbogen share price.

Also read: Adani’s KCL Forms JV with Praneetha Ecocables to Manufacture Cables and Wires

DISHMAN CARBO AMCIS LTD

Trade

228.051.77 (0.78 %)

Updated - 20 March 2025
233.90day high
DAY HIGH
226.50day low
DAY LOW
684866
VOLUME (BSE)

Key Takeaways

  1. Dishman Carbogen’s France-based Carbogen Amcis SAS secures GMP compliance certificate.

  2. Certification granted by ANSM for the Saint-Beauzire site.

  3. Ensures quality and safety of API and highly potent drug production.

  4. Enhances Dishman Carbogen’s global pharmaceutical credibility.

  5. Positive outlook for Dishman Carbogen share price expected.

Also read: Setback for Vodafone Idea, Bharti Airtel as AGR Waiver No Longer Considered

Certification Significance and Impact

The GMP compliance certification from ANSM reinforces Carbogen Amcis SAS’s commitment to maintaining the highest standards in pharmaceutical manufacturing. The Saint-Beauzire site, a key facility in the production of APIs and complex drug substances, now meets European regulatory requirements for quality and safety.

With the pharmaceutical sector placing heightened emphasis on quality assurance, this certification significantly strengthens Dishman Carbogen’s reputation as a reliable contract manufacturing partner. The positive development is likely to attract new business opportunities and strategic collaborations, boosting the Dishman Carbogen share price in the process.

Certification Details

Site Name

Certification Authority

Certification Type

Date Granted

Saint-Beauzire

ANSM

GMP Compliance

19 March 2025

Market Response and Share Price Impact

The certification news is expected to have a favourable impact on the Dishman Carbogen share price, as it underscores the company’s commitment to quality and regulatory compliance. Investors are likely to view this achievement positively, given the heightened focus on quality standards in the pharmaceutical industry.

Moreover, the certification aligns with the company’s strategic goal of expanding its presence in regulated markets. With this recognition, Dishman Carbogen is poised to enhance its credibility as a leading global player in the API and drug development segment.

Dishman Carbogen’s successful acquisition of the GMP compliance certificate for its Saint-Beauzire site marks a significant milestone in its journey towards maintaining the highest quality standards. The certification not only strengthens the company’s market presence but also signals a potential positive impact on the Dishman Carbogen share price, reflecting increased investor confidence and business potential.

Also read: Vedanta Targets Zero Debt in 3-4 Years, Plans $3.5 Billion Reduction by 2027

Do you have a trading account app or demat account app?

You can open an account with Bajaj Broking in minutes.

Download the Bajaj Broking app now from Play Store or App Store.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text